Concepts (83)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Catheter Ablation | 7 | 2023 | 31 | 1.410 |
Why?
|
| Ventricular Premature Complexes | 6 | 2022 | 10 | 1.170 |
Why?
|
| Tachycardia, Ventricular | 4 | 2023 | 11 | 0.720 |
Why?
|
| Acute Coronary Syndrome | 3 | 2012 | 35 | 0.590 |
Why?
|
| Hemorrhage | 3 | 2019 | 46 | 0.550 |
Why?
|
| Myocardial Ischemia | 2 | 2018 | 72 | 0.530 |
Why?
|
| Heart Ventricles | 6 | 2023 | 121 | 0.520 |
Why?
|
| Electrocardiography | 7 | 2023 | 154 | 0.500 |
Why?
|
| Carcinoid Heart Disease | 1 | 2011 | 1 | 0.430 |
Why?
|
| Brain Ischemia | 3 | 2019 | 179 | 0.420 |
Why?
|
| Heart Conduction System | 2 | 2019 | 14 | 0.350 |
Why?
|
| Atrial Fibrillation | 2 | 2019 | 105 | 0.300 |
Why?
|
| Arrhythmias, Cardiac | 3 | 2023 | 33 | 0.280 |
Why?
|
| Defibrillators, Implantable | 2 | 2018 | 34 | 0.280 |
Why?
|
| Stroke | 2 | 2019 | 274 | 0.250 |
Why?
|
| Electrocardiography, Ambulatory | 2 | 2020 | 11 | 0.230 |
Why?
|
| Aged | 9 | 2020 | 6448 | 0.220 |
Why?
|
| Humans | 22 | 2023 | 34853 | 0.200 |
Why?
|
| Heart Diseases | 2 | 2020 | 99 | 0.190 |
Why?
|
| Middle Aged | 11 | 2022 | 9642 | 0.190 |
Why?
|
| Female | 15 | 2020 | 19873 | 0.190 |
Why?
|
| Bundle of His | 1 | 2019 | 3 | 0.190 |
Why?
|
| Tachycardia, Atrioventricular Nodal Reentry | 1 | 2019 | 2 | 0.180 |
Why?
|
| Fluoroscopy | 1 | 2019 | 7 | 0.180 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2019 | 5 | 0.180 |
Why?
|
| Body Surface Potential Mapping | 1 | 2019 | 4 | 0.180 |
Why?
|
| Tachycardia, Supraventricular | 1 | 2019 | 2 | 0.170 |
Why?
|
| Magnetics | 1 | 2019 | 36 | 0.170 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2019 | 11 | 0.170 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2019 | 15 | 0.170 |
Why?
|
| Treatment Outcome | 5 | 2022 | 1349 | 0.170 |
Why?
|
| Ventricular Function, Right | 1 | 2019 | 35 | 0.170 |
Why?
|
| Retrospective Studies | 6 | 2020 | 1961 | 0.170 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2018 | 12 | 0.170 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2018 | 19 | 0.170 |
Why?
|
| Foramen Ovale, Patent | 1 | 2018 | 5 | 0.170 |
Why?
|
| Male | 14 | 2022 | 18870 | 0.170 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2019 | 41 | 0.170 |
Why?
|
| Ventricular Fibrillation | 1 | 2018 | 8 | 0.160 |
Why?
|
| Hypercalcemia | 1 | 2018 | 12 | 0.160 |
Why?
|
| Heart Rate | 1 | 2019 | 248 | 0.160 |
Why?
|
| Anticoagulants | 1 | 2019 | 97 | 0.160 |
Why?
|
| Incidence | 3 | 2019 | 882 | 0.150 |
Why?
|
| Follow-Up Studies | 4 | 2019 | 964 | 0.140 |
Why?
|
| Prognosis | 2 | 2020 | 707 | 0.120 |
Why?
|
| Brugada Syndrome | 1 | 2013 | 2 | 0.120 |
Why?
|
| Triazines | 1 | 2013 | 19 | 0.120 |
Why?
|
| Antidepressive Agents | 1 | 2013 | 53 | 0.120 |
Why?
|
| Risk Assessment | 2 | 2019 | 727 | 0.120 |
Why?
|
| Erythrocyte Indices | 1 | 2012 | 13 | 0.110 |
Why?
|
| Cardiovascular Diseases | 1 | 2019 | 628 | 0.110 |
Why?
|
| Ultrasonography | 1 | 2011 | 115 | 0.100 |
Why?
|
| Time Factors | 3 | 2019 | 1681 | 0.090 |
Why?
|
| Hospital Mortality | 1 | 2011 | 183 | 0.090 |
Why?
|
| Echocardiography, Doppler | 2 | 2019 | 39 | 0.090 |
Why?
|
| Portugal | 2 | 2019 | 9 | 0.090 |
Why?
|
| Risk Factors | 4 | 2019 | 3414 | 0.080 |
Why?
|
| Prospective Studies | 2 | 2022 | 1353 | 0.070 |
Why?
|
| Aged, 80 and over | 3 | 2019 | 2333 | 0.070 |
Why?
|
| Diagnostic Imaging | 1 | 2023 | 53 | 0.060 |
Why?
|
| Polyvinyl Chloride | 1 | 2022 | 4 | 0.060 |
Why?
|
| Heart | 1 | 2023 | 178 | 0.050 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2019 | 8 | 0.050 |
Why?
|
| Diastole | 1 | 2019 | 46 | 0.040 |
Why?
|
| Adult | 3 | 2019 | 11034 | 0.040 |
Why?
|
| Quinidine | 1 | 2018 | 1 | 0.040 |
Why?
|
| Hyperparathyroidism | 1 | 2018 | 5 | 0.040 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2018 | 11 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2019 | 212 | 0.040 |
Why?
|
| Isoproterenol | 1 | 2018 | 35 | 0.040 |
Why?
|
| Recurrence | 1 | 2018 | 125 | 0.040 |
Why?
|
| Cause of Death | 1 | 2019 | 154 | 0.040 |
Why?
|
| Action Potentials | 1 | 2019 | 219 | 0.040 |
Why?
|
| Prevalence | 1 | 2022 | 1425 | 0.040 |
Why?
|
| Survival Rate | 1 | 2018 | 310 | 0.040 |
Why?
|
| Echocardiography | 1 | 2017 | 144 | 0.040 |
Why?
|
| Comorbidity | 1 | 2019 | 606 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2019 | 1056 | 0.030 |
Why?
|
| Myocardial Infarction | 1 | 2017 | 221 | 0.030 |
Why?
|
| Equipment Failure | 1 | 2013 | 11 | 0.030 |
Why?
|
| Hospitalization | 1 | 2017 | 370 | 0.030 |
Why?
|
| Equipment Design | 1 | 2013 | 127 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2010 | 469 | 0.020 |
Why?
|